Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping
The discovery of circulating cell-free fetal DNA in maternal plasma has opened up new possibilities for noninvasive prenatal diagnosis. Fetal DNA in maternal plasma has been used for the noninvasive prenatal determination of the RhD status of fetuses carried by RhD-negative pregnant women. In such a...
Gespeichert in:
| Veröffentlicht in: | Transfusion clinique et biologique (Paris) 2006-03, Vol.13 (1), p.50-52 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 52 |
|---|---|
| container_issue | 1 |
| container_start_page | 50 |
| container_title | Transfusion clinique et biologique (Paris) |
| container_volume | 13 |
| creator | Lo, Y.M.D. |
| description | The discovery of circulating cell-free fetal DNA in maternal plasma has opened up new possibilities for noninvasive prenatal diagnosis. Fetal DNA in maternal plasma has been used for the noninvasive prenatal determination of the RhD status of fetuses carried by RhD-negative pregnant women. In such analysis, the possible need of an internal control for the presence of detectable amounts of fetal DNA in a particular maternal plasma sample has been actively discussed. Recently, the development of a robust method for discriminating single nucleotide differences in plasma DNA using single allele base extension reaction (SABER) followed by matrix-assisted laser-desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS) has opened up the possibilities of using a panel of single nucleotide polymorphisms as such a positive control. A second approach is the recent successful development of fetal epigenetic markers which can be developed into universal fetal DNA markers. These developments hold promise to allow the eventual widespread utilization of maternal plasma DNA analysis for the noninvasive prenatal diagnosis of blood group mismatches between the mother and fetus. |
| doi_str_mv | 10.1016/j.tracli.2006.02.010 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67895022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1246782006000085</els_id><sourcerecordid>67895022</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-777b2f1a60180b6ad5eb71a3482204ccec1c93a01d82efa3a81efe380f9b25443</originalsourceid><addsrcrecordid>eNp9kM9q3DAQh3VIadJt3yAUX9rbuiPZK9k9FEroPwgUQnoWY3m8aJElV5IXcs6L5FnyZPXihdx6mmHmmx_Dx9g1h5IDl58OZY5onC0FgCxBlMDhgl1xUcutagRcsjcpHQC44q16zS653MmqqeQVe7wjQz4XPR3JhWlc-lRY__w0UEZX-Nk4sqZAY_t1PmKm6JfV5DCN-Lmw4-SswWyDT0UOz08-eOuPmOyRiimSx1PQGte5EPpiH8M8FXvyIT9M1u_fslcDukTvznXD_nz_dn_zc3v7-8evm6-3W1O1kLdKqU4MHCXwBjqJ_Y46xbGqGyGgNoYMN22FwPtG0IAVNpwGqhoY2k7s6rrasI9r7hTD35lS1qNNhpxDT2FOWqqm3YEQC1ivoIkhpUiDnqIdMT5oDvokXB_0KlyfhGsQehG-nL0_58_dSP3L0dn2Anw4A5gMuiGiNza9cEpxrhZyw76sHC02jpaiTsaSN9TbSCbrPtj_f_IPRaqoXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67895022</pqid></control><display><type>article</type><title>Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Lo, Y.M.D.</creator><creatorcontrib>Lo, Y.M.D.</creatorcontrib><description>The discovery of circulating cell-free fetal DNA in maternal plasma has opened up new possibilities for noninvasive prenatal diagnosis. Fetal DNA in maternal plasma has been used for the noninvasive prenatal determination of the RhD status of fetuses carried by RhD-negative pregnant women. In such analysis, the possible need of an internal control for the presence of detectable amounts of fetal DNA in a particular maternal plasma sample has been actively discussed. Recently, the development of a robust method for discriminating single nucleotide differences in plasma DNA using single allele base extension reaction (SABER) followed by matrix-assisted laser-desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS) has opened up the possibilities of using a panel of single nucleotide polymorphisms as such a positive control. A second approach is the recent successful development of fetal epigenetic markers which can be developed into universal fetal DNA markers. These developments hold promise to allow the eventual widespread utilization of maternal plasma DNA analysis for the noninvasive prenatal diagnosis of blood group mismatches between the mother and fetus.</description><identifier>ISSN: 1246-7820</identifier><identifier>DOI: 10.1016/j.tracli.2006.02.010</identifier><identifier>PMID: 16563836</identifier><language>eng</language><publisher>Paris: Elsevier SAS</publisher><subject>acides nucléiques circulants ; ADN plasmatique ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Blood Group Antigens - genetics ; Blood Group Incompatibility - diagnosis ; Blood Group Incompatibility - embryology ; Blood Grouping and Crossmatching - methods ; Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis ; Circulating nucleic acids ; Diagnostic prénatal non invasif ; DNA - blood ; DNA Methylation ; Emergency and intensive respiratory care ; Epigenesis, Genetic ; Erythroblastosis, Fetal - prevention & control ; Female ; Fetal Blood - immunology ; Fetal DNA in maternal plasma ; Fetomaternal Transfusion ; Genotype ; Gynecology. Andrology. Obstetrics ; Humans ; Intensive care medicine ; Management. Prenatal diagnosis ; Medical sciences ; Noninvasive prenatal diagnosis ; Plasma DNA ; Plasma maternel ; Polymorphism, Single Nucleotide ; Pregnancy ; Pregnancy. Fetus. Placenta ; Prenatal Diagnosis - methods ; Rh Isoimmunization ; Rh-Hr Blood-Group System - genetics ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><ispartof>Transfusion clinique et biologique (Paris), 2006-03, Vol.13 (1), p.50-52</ispartof><rights>2006 Elsevier SAS</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-777b2f1a60180b6ad5eb71a3482204ccec1c93a01d82efa3a81efe380f9b25443</citedby><cites>FETCH-LOGICAL-c390t-777b2f1a60180b6ad5eb71a3482204ccec1c93a01d82efa3a81efe380f9b25443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.tracli.2006.02.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3549,23929,23930,25139,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17711738$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16563836$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lo, Y.M.D.</creatorcontrib><title>Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping</title><title>Transfusion clinique et biologique (Paris)</title><addtitle>Transfus Clin Biol</addtitle><description>The discovery of circulating cell-free fetal DNA in maternal plasma has opened up new possibilities for noninvasive prenatal diagnosis. Fetal DNA in maternal plasma has been used for the noninvasive prenatal determination of the RhD status of fetuses carried by RhD-negative pregnant women. In such analysis, the possible need of an internal control for the presence of detectable amounts of fetal DNA in a particular maternal plasma sample has been actively discussed. Recently, the development of a robust method for discriminating single nucleotide differences in plasma DNA using single allele base extension reaction (SABER) followed by matrix-assisted laser-desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS) has opened up the possibilities of using a panel of single nucleotide polymorphisms as such a positive control. A second approach is the recent successful development of fetal epigenetic markers which can be developed into universal fetal DNA markers. These developments hold promise to allow the eventual widespread utilization of maternal plasma DNA analysis for the noninvasive prenatal diagnosis of blood group mismatches between the mother and fetus.</description><subject>acides nucléiques circulants</subject><subject>ADN plasmatique</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Blood Group Antigens - genetics</subject><subject>Blood Group Incompatibility - diagnosis</subject><subject>Blood Group Incompatibility - embryology</subject><subject>Blood Grouping and Crossmatching - methods</subject><subject>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</subject><subject>Circulating nucleic acids</subject><subject>Diagnostic prénatal non invasif</subject><subject>DNA - blood</subject><subject>DNA Methylation</subject><subject>Emergency and intensive respiratory care</subject><subject>Epigenesis, Genetic</subject><subject>Erythroblastosis, Fetal - prevention & control</subject><subject>Female</subject><subject>Fetal Blood - immunology</subject><subject>Fetal DNA in maternal plasma</subject><subject>Fetomaternal Transfusion</subject><subject>Genotype</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Management. Prenatal diagnosis</subject><subject>Medical sciences</subject><subject>Noninvasive prenatal diagnosis</subject><subject>Plasma DNA</subject><subject>Plasma maternel</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Pregnancy</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Prenatal Diagnosis - methods</subject><subject>Rh Isoimmunization</subject><subject>Rh-Hr Blood-Group System - genetics</subject><subject>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><issn>1246-7820</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM9q3DAQh3VIadJt3yAUX9rbuiPZK9k9FEroPwgUQnoWY3m8aJElV5IXcs6L5FnyZPXihdx6mmHmmx_Dx9g1h5IDl58OZY5onC0FgCxBlMDhgl1xUcutagRcsjcpHQC44q16zS653MmqqeQVe7wjQz4XPR3JhWlc-lRY__w0UEZX-Nk4sqZAY_t1PmKm6JfV5DCN-Lmw4-SswWyDT0UOz08-eOuPmOyRiimSx1PQGte5EPpiH8M8FXvyIT9M1u_fslcDukTvznXD_nz_dn_zc3v7-8evm6-3W1O1kLdKqU4MHCXwBjqJ_Y46xbGqGyGgNoYMN22FwPtG0IAVNpwGqhoY2k7s6rrasI9r7hTD35lS1qNNhpxDT2FOWqqm3YEQC1ivoIkhpUiDnqIdMT5oDvokXB_0KlyfhGsQehG-nL0_58_dSP3L0dn2Anw4A5gMuiGiNza9cEpxrhZyw76sHC02jpaiTsaSN9TbSCbrPtj_f_IPRaqoXg</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>Lo, Y.M.D.</creator><general>Elsevier SAS</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060301</creationdate><title>Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping</title><author>Lo, Y.M.D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-777b2f1a60180b6ad5eb71a3482204ccec1c93a01d82efa3a81efe380f9b25443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>acides nucléiques circulants</topic><topic>ADN plasmatique</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Blood Group Antigens - genetics</topic><topic>Blood Group Incompatibility - diagnosis</topic><topic>Blood Group Incompatibility - embryology</topic><topic>Blood Grouping and Crossmatching - methods</topic><topic>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</topic><topic>Circulating nucleic acids</topic><topic>Diagnostic prénatal non invasif</topic><topic>DNA - blood</topic><topic>DNA Methylation</topic><topic>Emergency and intensive respiratory care</topic><topic>Epigenesis, Genetic</topic><topic>Erythroblastosis, Fetal - prevention & control</topic><topic>Female</topic><topic>Fetal Blood - immunology</topic><topic>Fetal DNA in maternal plasma</topic><topic>Fetomaternal Transfusion</topic><topic>Genotype</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Management. Prenatal diagnosis</topic><topic>Medical sciences</topic><topic>Noninvasive prenatal diagnosis</topic><topic>Plasma DNA</topic><topic>Plasma maternel</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Pregnancy</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Prenatal Diagnosis - methods</topic><topic>Rh Isoimmunization</topic><topic>Rh-Hr Blood-Group System - genetics</topic><topic>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lo, Y.M.D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transfusion clinique et biologique (Paris)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lo, Y.M.D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping</atitle><jtitle>Transfusion clinique et biologique (Paris)</jtitle><addtitle>Transfus Clin Biol</addtitle><date>2006-03-01</date><risdate>2006</risdate><volume>13</volume><issue>1</issue><spage>50</spage><epage>52</epage><pages>50-52</pages><issn>1246-7820</issn><abstract>The discovery of circulating cell-free fetal DNA in maternal plasma has opened up new possibilities for noninvasive prenatal diagnosis. Fetal DNA in maternal plasma has been used for the noninvasive prenatal determination of the RhD status of fetuses carried by RhD-negative pregnant women. In such analysis, the possible need of an internal control for the presence of detectable amounts of fetal DNA in a particular maternal plasma sample has been actively discussed. Recently, the development of a robust method for discriminating single nucleotide differences in plasma DNA using single allele base extension reaction (SABER) followed by matrix-assisted laser-desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS) has opened up the possibilities of using a panel of single nucleotide polymorphisms as such a positive control. A second approach is the recent successful development of fetal epigenetic markers which can be developed into universal fetal DNA markers. These developments hold promise to allow the eventual widespread utilization of maternal plasma DNA analysis for the noninvasive prenatal diagnosis of blood group mismatches between the mother and fetus.</abstract><cop>Paris</cop><pub>Elsevier SAS</pub><pmid>16563836</pmid><doi>10.1016/j.tracli.2006.02.010</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1246-7820 |
| ispartof | Transfusion clinique et biologique (Paris), 2006-03, Vol.13 (1), p.50-52 |
| issn | 1246-7820 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67895022 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | acides nucléiques circulants ADN plasmatique Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Blood Group Antigens - genetics Blood Group Incompatibility - diagnosis Blood Group Incompatibility - embryology Blood Grouping and Crossmatching - methods Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis Circulating nucleic acids Diagnostic prénatal non invasif DNA - blood DNA Methylation Emergency and intensive respiratory care Epigenesis, Genetic Erythroblastosis, Fetal - prevention & control Female Fetal Blood - immunology Fetal DNA in maternal plasma Fetomaternal Transfusion Genotype Gynecology. Andrology. Obstetrics Humans Intensive care medicine Management. Prenatal diagnosis Medical sciences Noninvasive prenatal diagnosis Plasma DNA Plasma maternel Polymorphism, Single Nucleotide Pregnancy Pregnancy. Fetus. Placenta Prenatal Diagnosis - methods Rh Isoimmunization Rh-Hr Blood-Group System - genetics Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Transfusions. Complications. Transfusion reactions. Cell and gene therapy |
| title | Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T07%3A42%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20developments%20in%C2%A0fetal%20nucleic%20acids%20in%C2%A0maternal%20plasma:%20implications%20to%C2%A0noninvasive%20prenatal%20fetal%20blood%20group%20genotyping&rft.jtitle=Transfusion%20clinique%20et%20biologique%20(Paris)&rft.au=Lo,%20Y.M.D.&rft.date=2006-03-01&rft.volume=13&rft.issue=1&rft.spage=50&rft.epage=52&rft.pages=50-52&rft.issn=1246-7820&rft_id=info:doi/10.1016/j.tracli.2006.02.010&rft_dat=%3Cproquest_cross%3E67895022%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67895022&rft_id=info:pmid/16563836&rft_els_id=S1246782006000085&rfr_iscdi=true |